EFFECT OF ANTIPSYCHOTIC-DRUGS AND THEIR CLINICALLY INACTIVE ANALOGS ON DOPAMINE METABOLISM

被引:24
|
作者
STANLEY, M [1 ]
WILK, S [1 ]
机构
[1] CUNY, MT SINAI SCH MED, DEPT PHARMACOL, NEW YORK, NY 10029 USA
关键词
D O I
10.1016/0014-2999(77)90302-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:293 / 302
页数:10
相关论文
共 50 条
  • [1] METABOLISM AND PHARMACOKINETICS OF ANTIPSYCHOTIC-DRUGS
    JORGENSEN, A
    PROGRESS IN DRUG METABOLISM, 1986, 9 : 111 - 174
  • [3] ANTIPSYCHOTIC-DRUGS
    MARDER, JE
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1976, 10 (01): : 54 - 54
  • [4] SEROTONIN-DOPAMINE INTERACTIONS AND ATYPICAL ANTIPSYCHOTIC-DRUGS
    MELTZER, HY
    PSYCHIATRIC ANNALS, 1993, 23 (04) : 193 - 200
  • [5] NMDA DOPAMINE INTERACTIONS - A NOVEL TARGET FOR ANTIPSYCHOTIC-DRUGS
    IVERSEN, SD
    JOURNAL OF NEUROCHEMISTRY, 1993, 61 : S240 - S240
  • [6] EFFECTS OF ANTIPSYCHOTIC-DRUGS ON DOPAMINE RECEPTORS IN APLYSIA NEURONS
    HEISS, WD
    HOYER, J
    THALHAMMER, G
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1975, 359 : R84 - R84
  • [7] INVIVO OCCUPANCY OF DOPAMINE-RECEPTORS BY ANTIPSYCHOTIC-DRUGS
    MELTZER, HY
    STOCKMEIER, CA
    ARCHIVES OF GENERAL PSYCHIATRY, 1992, 49 (07) : 588 - 589
  • [8] THIORIDAZINE - CENTRAL DOPAMINE TURNOVER AND CLINICAL EFFECTS OF ANTIPSYCHOTIC-DRUGS
    BOWERS, MB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1975, 17 (01) : 73 - 78
  • [9] ENHANCEMENT OF DOPAMINE METABOLISM IN RAT-BRAIN FRONTAL-CORTEX - A COMMON EFFECT OF CHRONICALLY ADMINISTERED ANTIPSYCHOTIC-DRUGS
    MEFFORD, IN
    ROTH, KA
    AGREN, H
    BARCHAS, JD
    BRAIN RESEARCH, 1988, 475 (02) : 380 - 384
  • [10] NOVEL DOPAMINE-RECEPTOR SUBTYPES AS TARGETS FOR ANTIPSYCHOTIC-DRUGS
    SOKOLOFF, P
    DIAZ, J
    LEVESQUE, D
    PILON, C
    DIMITRIADOU, V
    GRIFFON, N
    LAMMERS, CH
    MARTRES, MP
    SCHWARTZ, JC
    DIVERSITY OF INTERACTING RECEPTORS, 1995, 757 : 278 - 292